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Abstract
Determining the presence of sperm cells on an item or swab is often a crucial component of sexual offence investigation.
However, traditional histological staining techniques used for the morphological identification of spermatozoa lack both spec-
ificity and sensitivity, making analysis a complex and time-consuming process. New methods for the detection of sperm cells
based on aptamer recognition may be able to overcome these issues. In this work, we present the selection of ssDNA aptamers
against human sperm cells using Cell-SELEX and massively parallel sequencing technologies. A total of 14 rounds of selection
were performed following a modified Cell-SELEX protocol, which included additional steps for the isolation of spermatozoa
from seminal fluid. Massively parallel sequencing using the Illumina Miseq platform was conducted on enriched aptamer pools
to elucidate the structure of potential binders. A custom bioinformatics pipeline was also developed using Galaxy for the
automated processing of sequencing datasets. This data revealed several promising aptamer candidates, which were shown to
selectively bind sperm cells through both microscale thermophoresis and enzyme-linked oligonucleotide assays. These aptamers
have the potential to increase the efficiency of sexual offence casework by facilitating sperm detection.
Keywords Aptamers . Sperm cells . SELEX . Massively parallel sequencing . Next-generation sequencing . Microscale
thermophoresis
Introduction
Despite their increasing frequency, conviction rates for sexual
offences remain much lower than other violent crimes. In fact,
only 1.5% of rapes reported to the police result in the convic-
tion of a perpetrator [1]. Approximately half of these reported
cases fail to progress past the investigative stage of the crim-
inal justice process due to ‘evidence issues’ [2]. The effective
detection of forensic evidence has therefore become of para-
mount importance in sexual offence investigation as the pri-
mary method of linking an individual to a crime or exonerat-
ing those that have been wrongly accused.
One of the most valuable forms of forensic evidence in
cases of male-perpetrated sexual assault is the presence of
seminal fluid, either in the form of stains left behind on items
or on swabs taken from victims during a forensic medical
examination [3]. Methods used by forensic laboratories to
confirm the presence of semen are currently based on the
microscopic examination of sperm cells extracted from
suspected fluid samples [4]. This examination is often facili-
tated by the use of histological staining techniques designed to
enhance sperm cell visualization, allowing for easier assess-
ment of cell size, number, and morphology [5]. Despite rou-
tine use in forensic laboratories for over 40 years, stains such
as haematoxylin-eosin, Christmas tree, and alkaline fuchsin
are known to lack both specificity and sensitivity, making
the identification of sperm samples extremely challenging (es-
pecially if they are degraded, mixed, or contaminated) [6].
In recent years, several new assays for sperm cell detection
based on antibody recognition have appeared on the market in
an attempt to overcome these limitations. These assays, devel-
oped as part of the Sperm Hy-Liter product range, use
anti-sperm monoclonal antibodies functionalised with Alexa
488 fluorophores to label sperm cells, allowing them to be
visualized on glass slides using standard fluorescence micros-
copy [7]. However, despite initial promise, these techniques
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have yet to be widely adopted by the forensic community due
to the high cost associated with antibody-based testing re-
agents [8].
Emerging as a synthetic alternative to antibodies, aptamers
are short sequences of ssDNA or RNA that can be raised
in vitro to bind to virtually any given target [9]. Using the
Systematic Evolution of Ligands by Exponential Enrichment
(SELEX) process, aptamers can be selected against small mol-
ecules, large proteins, or whole cells through the cyclical
target-incubation and enrichment of randomized oligonucleo-
tide libraries [10]. Whilst analogous to antibodies in terms of
binding affinity, aptamers possess several advantages over
their protein counterparts, including enhanced stability [11],
greater speed of production [12], and ease of chemical modi-
f icat ion [13]. Importantly, aptamers can also be
mass-produced at low cost with no batch-to-batch variation
[14]. Given such advantages, we hypothesised that nucleic
acid aptamers may be a suitable substitute to antibodies for
use in sperm cell detection assays [15].
One attempt at producing oligonucleotide ligands towards
human sperm cells has already been undertaken by Katilius
et al. on behalf of Somalogic, Inc., a protein biomarker dis-
covery and diagnostics company, using a proprietary enrich-
ment method [16]. This study saw the development of
‘SOMAmer’ affinity reagents, ssDNA molecules modified
to include functional groups that mimic amino acid side
chains, for the purpose of capturing and separating sperm cells
from vaginal epithelial cells in forensic casework (rather than
for detection purposes). However, the sequence structures of
these reagents have yet to be disclosed. Another study by
Farini et al. also reported the development of aptamers specific
to heat-damaged bovine spermatozoa via the Cell-SELEX
process, demonstrating the suitability of this method for gen-
erating ligands towards whole sperm cell targets [17].
Efforts were therefore made towards the selection of
ssDNA aptamers against human sperm cells following a mod-
ified version of a popular Cell-SELEX protocol previously
reported by Sefah et al. [18]. This protocol included the use
of additional steps for the isolation of spermatozoa from
whole seminal fluid (rather than preparing cells through cul-
turing techniques), as well as the identification of potential
binding sequences by massively parallel sequencing (MPS,
also known as ‘next-generat ion sequencing’ and
‘high-throughput sequencing’). MPS was chosen for the anal-
ysis of enriched aptamer pools in order to increase the chances
of identifying binding candidates at a much earlier stage of
selection, provide a greater level of sequence information
from pooled samples, and avoid the time-consuming cloning
and colony-picking processes associated with conventional
Sanger sequencing. A bespoke bioinformatics pipeline was
also developed for the processing of these MPS datasets using
the web-based genomics toolset ‘Galaxy’ [19]. Whilst specif-
ically constructed for use within this study, this pipeline may
find extended use for the handling of MPS data obtained from
any future SELEX experiment employing a randomized N40
ssDNA library (or a library of any length given minor
workflow alterations). Aptamer candidates identified using
this pipeline were lastly tested for their ability to selectively
bind sperm cells over negative controls using two bimolecular
interaction analysis techniques, Microscale Thermophoresis
(MST) and enzyme-linked oligonucleotide assay (ELONA).
To the best of our knowledge, this study represents the very
first use ofMST to characterize the binding of aptamers to any
whole-cell target. Such aptamers may have the ability to
streamline forensic casework practices by allowing the detec-
tion of human sperm cells on objects or swabs with a higher
degree of specificity and sensitivity compared to traditional




For sperm cell isolation, Percoll was obtained from
Sigma-Aldrich (Dorset, UK). Human tubal fluid (HTF) was
prepared as a ×10 concentrate through the addition of 29.655 g
NaCl, 1.75 g KCl, 250 mg MgSO4·7H2O, 250 mg KH2PO4,
2.5 g glucose, 2.6 g HEPES, 1 g NaHCO3, 1.5 g CaCl2·2H2O,
and 3 g human serum albumin (HSA) to 350 mL sterile dis-
tilled water (SDW). This solution was then adjusted to pH 7.4
and made up to a total volume of 500 mL using SDW.
Dilution of this concentrate in SDW was used to prepare all
×1 HTF solutions.
For cell incubation and elution, an ssDNA library contain-
ing two fixed regions, each 18 nucleotides in length, flanking
randomized N40 base sequences, (5′-ATCCAGAGTGACGC
AGCA-N40-TGGACACGGTGGCTTAGT-3′) was obtained
(HPLC purified) from Integrated DNA technologies (IA,
USA). Aptamer binding buffer was prepared through the ad-
dition of 2.25 g glucose, 500 mg BSA, and 238 mg MgCl2 to
500 mL of ×1 phosphate-buffered saline (PBS).
All PCR reaction components, including ×10 PCR buffer,
50 mM MgCl2 solution, 10 mM dNTP mixture, and Platinum
Taq DNA polymerase were obtained from Thermo Fisher
Scientific (CA, USA). Fluorescently labelled forward
(5 ′ -6-FAM-ATCCAGAGTGACGCAGCA-3 ′ ) and
biotin-functionalised reverse (5′-biotin-ACTAAGCCACCGTG
TCCA-3′) primers were both obtained (HPLC purified) from
Integrated DNA technologies (IA, USA). Non-labelled versions
of both forward and reverse sequences were also procured.
For gel electrophoresis, agarose was obtained from
Sigma-Aldrich (Dorset, UK). Tris-Acetate-EDTA (TAE)
buffer (×50) and GelRed nucleic acid gel stain (×10,000 in
H2O) were both purchased from Cambridge Bioscience
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(Cambridge, UK), whilst HyperLadder 25 bp (also containing
×6 loading dye) was obtained from Bioline (Toronto,
Canada).
For the separation of double-stranded DNA (dsDNA),
Pierce NeutrAvidin agarose resin was purchased from
Thermo Fisher Scientific (CA, USA). Corning Costar
Spin-X and Amicon Ultra-0.5 mL (3 kDa MWCO) filter units
were both obtained from Sigma-Aldrich (Dorset, UK).
All DNA sequencing reagents, including the NEBNext
Ultra DNA Library Prep Kit for Illumina, NEBNext
Multiplex Oligos for Illumina (both New England Biolabs,
MA, USA), and Agencourt AMPure XP Beads (Beckman
Coulter, CA, USA), were provided by Dr. David Ballard from
DNA Analysis at King’s, King’s College London.
For ELONA, Nunc MaxiSorp™ flat-bottom 96-well
plates, 3,3′,5′-tetramethylbenzidine (TMB) substrate solutio,;
1 M sulphuric acid solution, and streptavidin-conjugated
horseradish peroxidase (SA-HRP) were all obtained from
Thermo Fisher Scientific (CA, USA).
Body fluid collection
Seminal fluid and saliva were obtained upon informed consent
from healthy donors and stored at 4 °C until the point of
analysis. Blood samples were drawn by venipuncture upon
informed consent from the same healthy donor and stored in
a BD Vacutainer Plus tube (Oxford, UK) containing 3.2%
sodium citrate coagulation preservative and stored at 4 °C
until analysis.
Ethical clearance for the collection and use of body fluids
for this study was granted by the King’s College London
Biomedical Sciences, Dentistry, Medicine and Natural &
Mathematical Sciences Research Ethics Subcommittee (refer-
ence number HR-17/18-5057). All experiments were per-
formed in accordance with the Human Tissue Act 2004.
Sperm cell isolation
Isolation of sperm cells from whole seminal fluid was per-
formed using density gradient centrifugation methods
outlined by the World Health Organization (WHO) [20].
First, an isotonic gradient was prepared through the addition
of 1 mL of ×10 HTF to 9 mL of Percoll. This gradient was
separated into two fractions which were then diluted in ×1
HTF to form 80% and 40% (v/v) Percoll suspensions. A
2 mL volume of the 40% suspension was then layered over
the top of 2 mL of the 80% suspension in a 15-mL tube to
create a discontinuous density gradient. Seminal fluid (1 mL)
was then added to the top of the gradient and centrifuged for
20 min at 500 g. The ensuing supernatant was removed from
the pelleted cells, which were then re-suspended and washed
twice with 5 mL of ×1 HTF. Pelleted sperm cells were lastly
re-suspended in 2 mL of SDW.
Cell concentrations were determined using a Countess II
automated cell counter (Thermo Fisher Scientific, CA, USA)




For the first round of the Cell-SELEX process, 100 μL of
100 μM (10 nmol) N40 ssDNA library was added to
270 μL of aptamer binding buffer, heated to 95 °C for
5 min, and allowed to cool to room temperature. During this
period, a volume of sperm cell suspension (obtained from the
same single donor) yielding a total of 1 × 107 cells was trans-
ferred into a 15-mL tube and centrifuged at 9000 g for 3 min.
The resulting supernatant was then removed before the
re-suspension of pelleted cells in 330 μL of aptamer binding
buffer. These cells were then added to the 370 μL of cooled
ssDNA library previously prepared and incubated for 1 h at 4 °
C on a rotary shaker.
After incubation, this mixture was centrifuged at 9000 g for
3 min in order to pellet cells and bound ssDNA sequences.
The resulting supernatant (comprised of remaining unbound
sequences was removed before cells were re-suspended and
washed (×3) with 1 mL of aptamer binding buffer. Bound
ssDNA sequences were then eluted from cells through the
addition of 500 μL DNase-free SDW with heating at 95 °C
for 10 min. A final centrifugation step at 9000 g for 10 min
was then used to pellet cells so that eluted sequences could be
collected in the ensuing supernatant.
In all subsequent selection rounds (2–14), incubation was
achieved through the addition of 200 μL ssDNA, diluted to a
concentration of 1 μM in aptamer binding buffer, to cells also
suspended in 200 μL of binding buffer. The total number of
cells used for incubation was reduced by one million each
cycle between SELEX rounds 2–5 (from 5 × 106 to 1 × 106
cells), in order to increase the stringency of the selection pro-
cess. A total of 1 × 106 cells were used in all further incuba-
tions (from rounds 6–14). Elution of sequences from cells in
rounds 2 to 14 was also conducted using 600 μL of binding
buffer, rather than 500 μL of SDW.
PCR amplification
In total, three different types of PCR amplification were per-
formed throughout the SELEX process: (1) pre-PCR, (2) trial
PCR, and (3) preparative PCR. However, the former of these
was only carried out during the first round of selection.
After the first incubation of N40 ssDNA library with cells,
pre-PCR amplification of the entire eluted pool was conducted
to create multiple representative copies of all possible bound
sequences, thereby avoiding the potential loss of aptamers
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during subsequent pipetting processes. This was achieved
through the addition of 500 μL eluted sequences to 500 μL
of a pre-PCRmix (Table 1), which was then run as 20 separate
50 μL reactions for 9 cycles on a Perkin-Elmer 9700 thermal
cycler (Cambridge, UK) using the temperature programme
found in Table 2.
Trial PCR reactions of ssDNA eluted during each round of
selection were carried out in order to determine the optimum
number of amplification cycles required for subsequent pre-
parative PCRs. This was conducted through the preparation of
a trial PCR reaction mix, which was then split into six indi-
vidual 45 μL volumes. To each of these volumes, 5 μL of
eluted ssDNAwas added, with the exception of one sample, to
which SDW was instead used in order to act as a negative
control. All samples were run using the same thermal cycling
methods and temperature programme previously outlined,
with one tube containing eluted ssDNA removed after 6, 8,
10, 12, and 14 cycles. Negative control samples were run for a
maximum number of 14 cycles. Amplification products were
then loaded alongside a HyperLadder 25-bp size determina-
tion marker onto a 4% agarose gel (made in 1× TAE and
containing 0.01% GelRed), which was then run in 1× TAE
buffer at 80 V for 100 min.
In order to generate the amount of ssDNA required for
input into further selection rounds, 100 μL of ssDNA eluted
from each incubation was lastly amplified after addition to a
preparative PCR mix using the optimum number of cycles
established during trial PCRs. Samples were run in 20 sepa-
rate 50-μL reactions using the thermal cycling methods and
temperature programme previously described. Agarose gel
electrophoresis was used to confirm successful amplification
in the same manner as trial PCR studies.
Strand separation
With dsDNA generated as a result of the amplification pro-
cess, strand separation of PCR products from each round of
selection was conducted via the use of an avidin-labelled resin
to capture biotin-functionalised antisense strands. First,
200 μL Pierce NeutrAvidin agarose resin was added to two
Corning Costar Spin-X filter units, which were then centri-
fuged at 500 g for 1 min in order to remove storage buffer.
Resin beads were then preconditioned for 30 min using
500 μL of 200 mM NaOH to remove any labile avidin mol-
ecules, before further centrifugation under the same condi-
tions. Resins were then washed (×5) with 500 μL of ×1 PBS
with further centrifugation. Incubation of resin beads with
500 μL of preparative PCR products from each round of se-
lection was then conducted for 30 min on an orbital shaker to
bind dsDNA through biotin-avidin interaction. After this in-
cubation, resins were centrifuged and washed (×5) with PBS
in the same manner previously described. 500 μL of 200 mM
NaOH was then added to the NeutrAvidin beads in order to
separate fluorescently labelled sense strands, which were then
collected after centrifugation at 1000 g for 10 min.
To remove NaOH, obtained ssDNA was placed into two
Amicon Ultra-0.5 mL (3 kDa MWCO) filter units and centri-
fuged at 14,000 g for 30 min. DNase-free H2O (450 μL) was
then added to the filters, which were then subjected to further
centrifugation under the same conditions. De-salted ssDNA
was finally collected by placing the filter units upside down
in clean microfuge tubes and centrifuging at 1000 g for 7 min.
The concentration of ssDNA was lastly quantified using a
Table 1 Reaction mixtures used
for pre, trial, and preparative PCR
during the SELEX process
Reagents Pre-PCR (μL) Trial PCR (μL) Prep PCR (μL)
×10 PCR buffer 100.00 35.00 100.00
dNTP mixture (10 mM) 20.00 7.00 20.00
MgCl2 (50 mM) 40.00 14.00 40.00
Forward primer (100 μM) 5.00 1.75 5.00
Reverse primer (100 μM) 5.00 1.75 5.00
DNase-free SDW 327.00 254.45 727.00
Platinum Taq polymerase 3.00 1.05 3.00
Eluted ssDNA Pool 500.00 - 100.00
Table 2 Thermal cycling conditions used for pre, trial, and preparative
amplification reactions
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NanoDrop ND-1000 Spectrophotometer (Thermo Fisher
Scientific, CA, USA).
Massively parallel sequencing and data analysis
Enriched aptamer pools obtained from rounds 1, 2, 3, 8, 9, 10,
and 14 of selection were subjected to MPS to elucidate the
structure of potential binding sequences. First, dsDNA prod-
ucts were prepared from each pool by PCR amplification
using the same reaction mix (with the exception of
non-labelled primer sets), number of cycles, and temperature
programme previously employed during the preparative PCRs
for each respective round. Amplified products were then
quantified using a NanoDrop ND-1000 Spectrophotometer
(Thermo Fisher Scientific, CA, USA) before being diluted in
SDW to a concentration of 2 ng/μL.
Samples were then prepared for sequencing using the
NEBNext Ultra DNA Library Prep Kit for Illumina. Briefly,
1.4 μL End Prep Enzyme Mix and 2.9 μL End Repair
Reaction Buffer (×10) were added to 25 μL of each dsDNA
sample, which were then incubated for 30 min at room tem-
perature and 30 min at 65 °C. Adaptors were then ligated to
the ends of dsDNA sequences through the addition of 7.5 μL
Blunt/TA Ligase Master Mix, 1.25 μL NEBNext adaptor for
Illumina and 0.5 μL Ligation Enhancer. This mixture was
then incubated at room temperature for 15 min before the
addition of 2 μL USER Enzyme, with further incubation at
37 °C for 15 min. A post-ligation cleanup was then conducted
using AMPure XP Beads with sequences eluted in 10 μL of
10 mM Tris-HCl, pH 8.5. A further PCR amplification of
sequences was performed through the addition of 7.5 μL
adaptor-ligated dsDNA to 12.5 μL NEBNext Ultra II Q5
Master Mix, 2.5 μL index primer, and 2.5 μL Universal
PCR primer. This mixture was run for 8 cycles in a thermal
cycler using the temperature programme found in Table 3. A
final cleanup procedure was conducted using AMPure XP
Beads before elution in ×1 TE buffer. All prepared samples
were loaded onto a V2 reagent cartridge and sequenced using
the Illumina Miseq platform (CA, USA).
Data analysis of raw sequence reads was performed using
Galaxy, an open-source bioinformatics platform, following a
custom-developed pipeline adapted from previous work con-
ducted by Thiel et al. [21].
Microscale Thermophoresis
Aptamer sequences SP1 (5′-CACTCTCACCTTCCTGTCAC
TCCTTTTTTCACTCTCACTC-3 ′), SP2 (5 ′-CACT
CACTCTTTCCCTTATCTGCTCACTCTTCATTCAC
TC-3′), and SP3 (5′-CACCGTCCTTTTCTAGCATC
TCTGTCACTCTTTCTCACTC-3′) labelled with 5′ 6-FAM
fluorophores were synthesized by Integrated DNA
Technologies (IA, USA) and prepared to an initial stock con-
centration of 40 nM in PBS supplemented with 0.05%
Tween-20. Prior to use, all aptamer solutions were heated to
a temperature of 95 °C for 5 min and snap-cooled on ice. A
target dilution series was prepared by titrating sperm cells
suspended in SELEX buffer in 16 steps 1:1 from an initial
concentration of 2 × 107/mL. For the measurement of binding
affinity, 5 μL of each fluorescently labelled aptamer solution
(40 nM) was mixed with 5 μL of all sperm cell dilutions to
allow binding reactions to occur (with each sample prepared
in triplicate). Reaction mixtures were drawn up using standard
MST capillaries and loaded onto a Monolith NT.115 system
(NanoTemper Technologies GmbH, Germany) at an ambient
temperature of 25 °C. Instrument parameters were adjusted to
25% LED power and medium MST power for all samples.
Identical experiments were also performed using dilutions of
human red blood and salivary epithelial cells to assess the
potential for non-specific aptamer binding.
Data obtained from all sample replicates were analysed by
MO.Affinity Analysis software version 2.2.4, (NanoTemper
Technologies GmbH, Germany) using the signal from an
MST-on time of 15 s. Normalized fluorescence responses
were transformed to ΔFnorm (‰) values (by subtracting
baseline Fnorm values from all data points on the same curve)
in order to correct for baseline differences and allow manual
plotting against cell concentrations in a dose-response curve
using GraphPad Prism software version 8.4.1 (GraphPad, CA,
USA).
Enzyme-linked oligonucleotide assay
Aptamer sequences SP1, SP2, and SP3, as well as a random-
ized control sequence (5′-ACTAAGCCACCGTGTCCA-3′),
were synthesized with 5′ biotin groups by Integrated DNA
Technologies (IA, USA) and prepared to an initial stock con-
centration of 1 μM in PBS supplemented with 5 mM MgCl2,
0.05% Tween-20 and 1% BSA. Prior to use, all aptamer so-
lutions were heated to a temperature of 95 °C for 5 min and
snap-cooled on ice. A series of sperm cell dilutions (1:10,
1:100, 1:200, 1:400, 1:800, and 1:1000 in carbonate/
Table 3 Thermal cycling temperature programme used forMPS sample
preparation
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bicarbonate buffer pH 9.6, starting from an initial stock con-
centration of 4.7 × 106 cells/mL) were prepared from isolated
sperm samples obtained from three healthy donors. Each
sperm dilution sample was then added in a 100 μL volume
to a Nunc MaxiSorp flat-bottom 96-microwell plate (Thermo
Scientific, CA, USA) for 1 h at 37 °C to coat the sample wells.
After incubation, each plate was drained and all wells were
washed three times with ELONA wash buffer (PBS, 5 mM
MgCl2, Glucose and 0.05% Tween-20). Next, remaining well
surfaces were blocked by incubation with 200 μL ELONA
blocking buffer (PBS, 5 mM MgCl2 and 1% BSA) for 1 h at
room temperature on a rotary shaker. All wells were again
drained and washed three times with ELONA buffer before
the addition of 1 μM aptamer (or control sequence) with in-
cubation for 1 h on a rotary shaker. Plates were drained and
washed for a third time using ELONA wash buffer to remove
any unbound aptamers prior to the addition of 100 μL of 1 μg/
mL SA-HRP, with plates left for 45 min at room temperature
on a rotary shaker. A final drain and wash with ELONA wash
buffer was lastly performed on each plate before the addition
of 100 μL TMB substrate for 20min at room temperature with
shaking. TMB substrate reactions were paused using 50 μL
1 M sulphuric acid solution. Measurements of substrate ab-
sorbance were performed using an Opsys MR UV-Vis micro-
plate reader (Dynex Technologies, VA, USA) at 450 nm.
Results and discussion
Aptamer selection
Aptamers were selected according to a Cell-SELEX protocol
previously reported by Sefah et al. [18] with several modifi-
cations. First, as human sperm cells used for in vitro studies
are typically obtained from whole seminal fluid, rather than
via traditional culture techniques, pre-selection cell growth
and preparation methods were substituted with a density gra-
dient centrifugation–based sperm cell isolation process [20].
Microscopic examination of cells pre- and post-isolation con-
firmed the successful separation of spermatozoa from other
seminal leukocyte and epithelial cells (Fig. 1). Such isolation
is vital to ensuring that aptamers are not selected against
non-target cell types or other whole fluid components.
A randomized N40 ssDNA library containing fixed
flanking regions was incubated with a defined number of
sperm cells (which were progressively decreased between
SELEX cycles 1–5 from 5 × 106 to 1 × 106 cells and kept at
1 × 106 cells for all subsequent incubations) at the start of each
round of selection. Aptamers able to bind to sperm targets
were then recovered through centrifugation and eluted from
the surface of cells before undergoing PCR amplification (to
increase relative representation in subsequent selection
rounds).
Trial PCRs were first conducted to determine the number
of amplification cycles needed to generate the amounts of
DNA required for further aptamer-cell incubations.
Amplified products were successfully detected across all se-
lection cycles using agarose gel electrophoresis. These prod-
ucts were found to run at approximately the same speed as the
75-bp fragment of a utilized Hyperladder DNA standard,
which is consistent with the theoretical size (76 bp plus addi-
tional 6-FAM and biotin functionalisation) of dsDNA se-
quences (Fig. 2a).
One interesting effect observed during trial PCR analysis
was the presence of a secondary DNA band running slightly
slower than identified dsDNA products in samples amplified
over a certain number of cycles. This effect varied between
each selection round and was not found to be specific to a set
number of amplification cycles. Previous studies have attrib-
uted such effects to the formation of PCR by-products as a
result of the repetitive amplification of randomized ssDNA
libraries [22]. These by-products are likely to originate from
the hybridization of ssDNA sequences to complementary ba-
ses within the random N40 region, which then serve as PCR
primers. Extension of sequences at these priming regions by
DNA polymerases then results in the formation of longer
dsDNA products, which run at a marginally reduced speed
on electrophoretic gels. Consequently, optimal PCR cycle
numbers used for subsequent preparative amplifications were
chosen based on the trial PCR samples where only single
product bands were observed (Fig. 2b).
Double-stranded amplification products were then subject-
ed to strand separation using a Pierce NeutrAvidin agarose
resin and NaOH denaturation to recover sense ssDNA se-
quences. After desalting, aptamer pools were quantified be-
fore being diluted for input into subsequent SELEX round cell
incubations. A general increase in the concentration of recov-
ered ssDNA during each round of selection was observed
across up until round 11 of the Cell-SELEX process. This
increase may indicate the success of aptamer selection, with
greater target-sequence binding resulting in increased
amounts of eluted ssDNA template available for amplification
(which in turn results in higher PCR product concentrations).
Massively parallel sequencing and data analysis
Another modification made to the employed Cell-SELEX
protocol [18] included the use of MPS technologies to eluci-
date the sequences of potential binding ligands. Such technol-
ogies were chosen for use in this study to elicit a greater
amount of sequence information from enriched aptamer pools,
as well as to avoid the time-intensive cloning and
colony-picking methods associated with traditional Sanger se-
quencing. Several research groups have already shown the
effectiveness of MPS analysis within aptamer selection exper-
iments to allow for the detection of ligands at earlier rounds of
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selection and greater characterization of the evolution of
enriched pools between SELEX cycles [23–28].
Three separate instances of high-throughput sequencing
were conducted using the Illumina Miseq platform to deter-
mine the sequence and relative abundance of ssDNAs
contained within early (rounds 1–3), mid (rounds 8–10), and
late (round 14) SELEX cycle aptamer pools. Significant data
processing was required to isolate random N40 bases from
fixed flanking regions, as well as to remove any undesirable
selection and/or sequencing artefacts. Such artefacts include
sequences of incorrect length (originating as amplification
by-products as already discussed) or those containing mis-
matched constant regions.
This was achieved using Galaxy, an online bioinformatics
management system that allows the construction of custom
data processing workflows for the analysis of complex geno-
mics datasets [29]. A Cell-SELEX workflow (made available
at https://usegalaxy.org/u/jamesgooch/w/cell-selex) for the
processing of MPS data obtained from this study was
developed according to methods reported by Thiel et al.
[21]. This automated pipeline is able to provide collated
sequence and read count information from a single input of
generated raw forward and reverse-read FASTQ files without
further user contribution (Fig. 3). The individual steps of this
workflow (as separate Galaxy ‘tools’) were as follows:
1. Upload—FASTQ files from both forward and reverse
sequences reads for a given round of selection are first
uploaded to the Galaxy web server.
2. FASTQ.Joiner—Both forward and reverse paired-end
sequence reads are merged together, allowing the simul-
taneous processing of datasets.
3. FASTQ to FASTA—Phred quality scores assigned to
each nucleotide are removed by converting files to a
FASTA format.
4. FASTA-to-Tabular—Files are then converted to a
text-based format that allows for easier sequence
manipulation.
5. Cut—The unique identifier assigned to each read is re-
moved, leaving only raw sequence data.
6. Text Formatting—Sequences that do not meet specific
text-based criteria are removed from the dataset. In this
workflow, sequences are retained if both constant
flanking regions, as well as a central series of nucleotides
of 38–42 bases in length, are present. Longer amplifica-
tion by-products are removed at this stage.
Fig. 2 Gel electrophoresis images of a trial and b preparative PCR amplifications from the 4th round of the sperm cell aptamer selection process. Lane
legends represent the number of amplification cycles performed or negative (Neg.) control samples
Fig. 1 Microscopic examination
of haemotoxylin and eosin-
stained sperm cells. a Pre- and b
post-isolation using a density
gradient centrifugation procedure
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Fig. 3 Scheme of the developed Cell-SELEX Galaxy pipeline and example data outputs
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7. Replace—A comma character is placed at the end of 5′
constant flanking sequences, separating them from cen-
tral N38-42 base regions.
8. Convert—Sequences are split based on the position of
inserted comma values, placing 5′ constant regions into a
separate column.
9. Cut—Columns containing 5′ constant region sequences
are subsequently removed from the dataset.
10. Replace, convert, cut—Steps 7–9 of the workflow are
repeated in order to remove 3′ flanking regions, which
are separated by placing a comma character at the begin-
ning of the constant sequence. After this stage, only
N38-42 sequences are present within the dataset.
11. Add Column—An additional column is added to the
dataset containing arbitrary ‘+’ character values against
each sequence. These values act as sequence identifiers,
allowing file conversion to a FASTA format.
12. Tabular-to-FASTA—Files are converted back from tab-
ular to FASTA file formats, allowing for the sequences
to be collapsed.
13. Collapse—Repeated identical sequences are reduced in-
to a single read and assigned a count value correspond-
ing to the number of duplicated sequences present within
a sample.
Whilst application of the developedGalaxy data processing
workflow resulted in a general decrease in the total number of
sequence reads in all MPS datasets, this reduction was found
to be less substantial for the sample obtained from the final
round of selection. Such results may potentially be taken as an
indication of successful selection, with increased enrichment
of viable aptamer sequences (that meet data processing param-
eters) compared to amplification of sequencing artefacts.
Despite the success of other research groups in using MPS
to identify viable aptamer candidates in less than 10 rounds of
selection, analysed samples obtained from early (rounds 1–3)
and mid (rounds 8–10) Cell-SELEX cycles did not contain
any sequences that were repeated more than twice (after data
processing). However, a total of 13,138 sequences were found
to be repeated multiple times in the MPS dataset obtained
from the final round of selection (round 14). In fact, 15 se-
quences were found to possess read counts greater than 25
(Table 4), thereby demonstrating potential for the recognition
of human sperm cells.
Microscale Thermophoresis
To confirm the binding of generated ligands to sperm cells,
sequences SP1, SP2, and SP3 (the three candidates displaying
the highest read counts from round 14 aptamer pool sequenc-
ing) were synthesized with 5′ 6-FAM fluorophores to enable
their use within MST interaction experiments. MST, or
‘thermo-optical measurement’, is a recently reported tech-
nique that exploits differences in the physical movements of
individual molecules passing through a spatial temperature
gradient [30]. This phenomenon, known as ‘thermophoresis’,
is largely dependent on the size, charge, and hydration shell
properties of a molecule, which can all be altered as a result of
a binding event (or associated conformational changes in-
duced within a binding ligand). MST analysis can therefore
be used to obtain accurate binding information from a sample
bymonitoring the concentration of fluorescently labelled mol-
ecules present within a defined region of elevated temperature,
and how this concentration changes as a result of ligand-target
interaction [31]. MST analysis was chosen for use within this
study due its ability to characterize binding events in free
solution, thereby avoiding the need for aptamer immobiliza-
tion (which can alter binding ability and decrease the accuracy
of interaction measurements).
Figure 4 shows normalized fluorescence changes for se-
quences SP1, SP2, and SP3 as a function of sperm cell con-
centration. With increased emission signals observed in re-
sponse to rising cell concentrations, these results successfully
demonstrate the binding of each aptamer candidate to its
intended target. It should be noted that whilst sequence SP1
displayed the highest MST response amplitude towards sperm
cells during binding experiments, sequence SP3 possessed the
highest average signal-to-noise ratio, which is often a better
indicator of the quality of binding data [32].
In the ‘WHO laboratory manual for the examination and
processing of human semen’, the reference range given for the
concentration of sperm cells in the ejaculate of a healthy indi-
vidual is 15–213 × 106/mL (5th and 95th centiles,
Table 4 Sequences obtained from round 14 of selection exhibiting
more than 25 total reads
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respectively) [20]. With positive increases in MST emission
signals observed during the incubation of each aptamer can-
didate with every sperm sample above a concentration of 10 ×
106/mL, confidence may be given in the ability of these
aptamers to bind sperm cells within neat semen samples ob-
tained as part of sexual assault investigations. Additionally,
whilst there is no ‘typical’ volume of semen recovered during
such investigations, the total volume of sperm cell samples
used during MST analysis was 5 μL, which would typically
be considered a ‘trace’ amount within forensic casework. It is
also important to note that no fluorescence changes were ob-
served during the incubation of all sperm cell samples with
sequences SP1, SP2, and SP3 containing constant region
sequences.
It should be noted that identical MST experiments were
also carried out using aptamers SP1, SP2, and SP3 synthe-
sized to include the constant region sequences utilized as part
of the Cell-SELEX process in order to examine potential ef-
fects on ligand-target binding. No fluorescence changes were
observed during the incubation of each of these sequences
with any sperm cell sample (subsequently preventing the plot-
ting ofMST dose-response curves), thereby demonstrating the
selectivity of interactions between sperm cells and original
SP1, SP2, and SP3 sequences not containing additional con-
stant regions.
One limitation associated with the use of MST analysis for
assessing the binding of fluorescent aptamers to whole-cells is
the inability to determine accurate equilibrium dissociation
constant (KD) values as a measure of binding affinity. This is
due to the fact that it is not possible to determine the exact
molar concentration of a target in a population of whole sperm
cells without radiolabelled aptamers [33, 34]. Previous studies
have attempted to overcome this issue by assigning arbitrary
molarity values to cell populations based on estimated poten-
tial concentration ranges [35]. However, the authors of these
studies have also questioned the reproducibility of this ap-
proach, given the variability of antigen expression between
cell batches [35]. A more suitable solution may be to conduct
MST experiments in which consistent concentrations of fluo-
rescently labelled sperm cells are incubated with a serial di-
lution of aptamers at known molarities, which could then be
used to calculate KD values. However, for this to occur, a
method for the reliable labelling of sperm cells with a consis-
tent number of fluorophores (and in a way that does not
inhibit aptamer binding) would first need to be identified.
Despite these limitations, MST analysis using fluorescently
labelled aptamers may still be considered a useful method for
providing a robust indication of successful aptamer-cell
binding.
MST experiments were also undertaken to assess the po-
tential for the non-specific binding of sequences SP1, SP2,
and SP3 to non-target cell types. For these experiments, hu-
man red blood cells and epithelial cells collected from human
saliva were chosen as negative controls for both their rele-
vance to forensic analysis and their ability to be isolated from
biological fluids, rather than prepared through cell culturing
techniques. These targets were tested against aptamer candi-
dates in the same manner as sperm cells. In all cases, no
interaction was observed between aptamers and negative con-
trol cells (Fig. 5). Such results demonstrate excellent selective-
ly of the selected aptamers increasing their potential for future
use within biosensing assays and other analytical platforms.
Enzyme-linked oligonucleotide assay
With previous studies demonstrating that proteins present on
the surface of human sperm cells are not only expressed dif-
ferently between individuals, but are also heterogeneously
expressed across cell populations obtained from the same in-
dividual [36], it is crucially important for any potential future
application to forensic casework that the aptamer sequences
reported here are capable of binding to sperm cells from dif-
ferent donors.
A series of additional binding experiments were therefore
undertaken, in which sequences SP1, SP2, and SP3 were in-
cubated with dilution series of sperm cells obtained from two
additional healthy donors (3 donors total) in enzyme-linked
oligonucleotide assays (ELONA). ELONA is a plate-based
technique for the detection of aptamer-target complexes, in
which a protein or whole-cell target is first absorbed to a solid
surface and subsequently incubated with biotinylated aptamer
(s). Streptavidin-conjugated horseradish peroxidase
(SA-HRP) is then conjugated to captured aptamers and used
to catalyse the reaction of a chromogenic substrate (the absor-
bance of which can be measured via UV-Vis spectroscopy)
[37]. This assay format was specifically selected to demon-
strate that interactions between sperm cells and generated
aptamer sequences can also be successfully observed through
binding characterization techniques other than MST.
Sperm cells at different dilutions (from 1:10 to 1:1000,
starting at an initial stock concentration of 4.7 × 106 cell/mL)
Fig. 4 MST dose-response curves for aptamer candidates SP1, SP2, and
SP3 against serially diluted sperm cell suspensions. Error bars = s.d.; n =
3 (independent experiments)
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were therefore first adsorbed to the wells of MaxiSorp™
flat-bottom 96-well plates for 1 h at 37 °C. Each well was then
washed three times with wash buffer to remove unbound cells
before the blocking of any remaining well surface through the
addition of a blocking buffer containing 1% BSA. Constant
concentrations of each biotinylated aptamer, along with a ran-
domized control sequence (5′-biotin-ACTAAGCCACCGTG
TCCA-3′), were then incubated with sperm dilution samples
(and with negative wells containing no cells) for 1 h at room
temperature. All wells were again washed three times with
wash buffer to remove unbound aptamers. Next, SA-HRP
was added to each sample for a period of 45 min to allow
conjugation to any biotinylated aptamers present on the sur-
face of adsorbed sperm cells. Any unbound enzyme was then
removed by a further three washes. Lastly, TMB substrate
solution was added to each well to react with HRP, forming
a colorimetric product, which after acidification with
sulphuric acid, allowed the observation of aptamer-target
binding through measuring sample absorbance at 450 nm.
Figure 6 shows ELONA absorbance values obtained fol-
lowing the incubation of aptamers SP1, SP2, and SP3 (as well
as a control sequence) with dilutions of sperm cells obtained
from three separate donors. For each donor/aptamer combina-
tion, consistent increases in absorbance were observed with
greater sperm cell concentrations, indicating dose-dependent
binding responses and demonstrating the ability of each
aptamer to interact with sperm cells from different individuals.
In general, sequence SP3 produced the greatest substrate re-
sponse across all donors, which is consistent with data from
MST characterization experiments, where the same sequence
produced the greatest signal-to-noise values. It is also impor-
tant to note that substrate absorbance responses observed upon
the incubation of the randomized control sequence with sperm
cell dilution samples from all donors were low in comparison
to those produced by SP 1–3, thereby demonstrating that
sperm cell binding is largely achieved as a result of the spe-
cific sequences of identified aptamers (and is not due to
non-specific ssDNA-cell interactions).
Conclusions
A number of promising ssDNA aptamer candidates have been
raised towards the recognition of human sperm cells using
in vitro Cell-SELEX and massively parallel sequencing
methods. A total of 14 rounds of selection were performed
following a previously reported Cell-SELEX protocol, which
was modified to include the isolation of sperm cells from
human seminal fluid.
MPS of enriched aptamer pools was also used to monitor
selection progress between rounds over traditional cloning
and Sanger sequencing methods. MPS analysis was chosen
for inclusion in this work for its ability to generate greater
sequence information from enriched aptamer pools, with the
Fig. 5 MST dose-response curves for aptamer candidates: a SP1; b SP2; and; c SP3 against serially diluted sperm cell, red blood cell, and epithelial cell
suspensions. Error bars = s.d.; n = 3 (independent experiments)
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additional possibility of identifying promising aptamer candi-
dates within a reduced number of selection rounds (although
this did not actually occur within this particular study).
A novel data processing pipeline was constructed using the
online informatics workflow management system Galaxy, for
elucidating the sequence structure of potential binding li-
gands. Whilst specifically developed for the analysis of data
obtained within this study, this pipeline may have potential
use in future SELEX experiments (towards both cellular and
non-cellular targets) employing a similar N40 library template
(although any library may be used through minor alterations
to the text files used to identify constant region sequences and
by defining an appropriate N region length).
Although these sperm cell–specific sequences were primar-
ily raised for use within forensic analysis, either as part of cell
identification assays or through the incorporation of se-
quences into solid-phase aptamer-functionalised materials
(AFMs) for the capture and isolation of spermatozoa from
vaginal epithelial cells, it is envisioned that such ligands
may also have application to other areas of biomedical testing,
including fertility evaluation.
To the best of our knowledge, this study also represents the
very first use of MST to characterize binding interactions be-
tween aptamers and whole cells. MST experiments conducted
in this work successfully established the ability of generated
aptamer candidates to selectively bind to sperm cells over a series
of non-target cells, whilst further ELONAexperiments also dem-
onstrated binding to cells obtained from different donors (in
comparison to a randomized negative control sequence).
However, further studies are needed to determine the specific
cell surface antigens involved in aptamer binding, before accu-
rate KD values can be obtained for these sequences.
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